ArticleBiomedicines2022

The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma.

Risa Tomioka-Inagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.